Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics
The central focus of the agreement is to establish peptide hits from selected library populations
Read More
Tag: cachexia therapeutics
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
